Abstract

Peanut allergy is a growing public health concern in westernized countries. Peanut allergy is characterized as an often severe and lifelong allergy, which can have detrimental effects on quality of life and trigger anxiety. Although multiple therapeutic options are emerging, the focus of current management strategies is strict peanut avoidance and carriage of self-injectable epinephrine. The greatest risk of reacting to peanut comes from direct ingestion, whereas casual skin contact or airborne exposure is highly unlikely to provoke significant symptoms. Patients and families must be educated about how to best execute strict peanut avoidance through careful label reading as well as how to understand and address likely and unlikely risk with regard to peanut exposure in public, in particular when dining outside of the home and for children attending school or child care. This review discusses the risk of exposure in public such as at school or on an airplane and how such risk can be abated, situations and scenarios when dining out of the house that may pose more risks than others, the essentials of US and EU label reading laws with particular emphasis on precautionary labeling and the risk implied by such, quality of life and psychosocial issues that may affect the peanut allergic individual and family, and a discussion of how risk may differ and evolve based on the patient's age.

Original languageEnglish
Pages (from-to)345-355.e2
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume7
Issue number2
DOIs
StatePublished - Feb 2019

Keywords

  • Allergen avoidance
  • Anaphylaxis
  • Epinephrine
  • Epinephrine auto-injector
  • Food allergy
  • Food allergy labeling
  • Peanut allergy
  • Peanut allergy management
  • Quality of life

Fingerprint

Dive into the research topics of 'Management of Peanut Allergy'. Together they form a unique fingerprint.

Cite this